Garry Arthur Neil
Director; Director, Chief Executive Officer · 4 filings · Latest: Jun 25, 2026
Avalo Therapeutics, Inc.
Celldex Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AVTX | Garry Arthur Neil | Director, Chief Executive Officer | Mar 28, 2026 | Option Exercise | — | 64,866 | — | 112,006 |